Nuveen LLC’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$377K Sell
336,872
-42,216
-11% -$47.3K ﹤0.01% 2966
2025
Q1
$300K Buy
+379,088
New +$300K ﹤0.01% 3045